Activest Wealth Management’s Quantum Biopharma Class B Subordinate Voting Shares QNTM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$54 Hold
15
﹤0.01% 1287
2026
Q1
$72 Hold
15
﹤0.01% 1169
2025
Q4
$110 Hold
15
﹤0.01% 1064
2025
Q3
$246 Hold
15
﹤0.01% 1007
2025
Q2
$304 Hold
15
﹤0.01% 929
2025
Q1
$116 Buy
+15
New +$86 ﹤0.01% 962

Other funds holding QNTM

Activest Wealth Management's QNTM Position: Q2 2026 in Review

Activest Wealth Management held its Quantum Biopharma Class B Subordinate Voting Shares (QNTM) position steady in Q2 2026 at 15 shares worth $54. The position accounts for ﹤0.01% of the portfolio, ranked #1287.

Activest Wealth Management first reported a position in QNTM in Q1 2025 and has held it in 6 quarters since. The position peaked at $304 in Q2 2025. 8 funds tracked by Wall St. Rank hold QNTM as of Q2 2026.

  • Activest Wealth Management held 15 shares of Quantum Biopharma Class B Subordinate Voting Shares worth $54 as of Q2 2026.
  • Activest Wealth Management left its Quantum Biopharma Class B Subordinate Voting Shares share count unchanged in Q2 2026.
  • Quantum Biopharma Class B Subordinate Voting Shares made up ﹤0.01% of Activest Wealth Management's portfolio in Q2 2026, its #1287 holding.
  • Activest Wealth Management first reported a position in Quantum Biopharma Class B Subordinate Voting Shares in Q1 2025 and has held it in 6 quarters since.
  • Activest Wealth Management's Quantum Biopharma Class B Subordinate Voting Shares position peaked at $304 in Q2 2025.
  • 8 funds tracked by Wall St. Rank held Quantum Biopharma Class B Subordinate Voting Shares as of Q2 2026.

Based on Activest Wealth Management's 13F filing for Q2 2026, filed 16 Jul 2026.